N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid

C58H77Cl2F3N14O12S2 — CID 157427964

IUPACN-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid
SMILESC.Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1C[C@@H](N)C[C@H]1CO.Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1C[C@@H](NC(=O)OC(C)(C)C)C[C@H]1CO.O=C(O)C(F)(F)F
InChIInChI=1S/C30H40ClN7O6S.C25H32ClN7O4S.C2HF3O2.CH4/c1-18-15-38-26(33-27(18)37-16-20(13-21(37)17-39)32-29(41)44-30(2,3)4)14-24(34-38)25-8-6-7-11-36(25)28(40)22-12-19(31)9-10-23(22)35-45(5,42)43;1-15-12-33-23(28-24(15)32-13-17(27)10-18(32)14-34)11-21(29-33)22-5-3-4-8-31(22)25(35)19-9-16(26)6-7-20(19)30-38(2,36)37;3-2(4,5)1(6)7;/h9-10,12,14-15,20-21,25,35,39H,6-8,11,13,16-17H2,1-5H3,(H,32,41);6-7,9,11-12,17-18,22,30,34H,3-5,8,10,13-14,27H2,1-2H3;(H,6,7);1H4/t20-,21-,25-;17-,18-,22-;;/m00../s1
InChIKeyXZGPUPNEELNTEG-MVYDLPHFSA-N
MW1354.37 g/mol
LogP7.49
Rot. Bonds13

About N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid

N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid (PubChem CID 157427964) has the molecular formula C58H77Cl2F3N14O12S2 and a molecular weight of 1354.37 g/mol. Its IUPAC name is N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid.

Molecular Properties

Compound NameN-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid
PubChem CID157427964
Molecular FormulaC58H77Cl2F3N14O12S2
Molecular Weight1354.37 g/mol
Exact Mass1352.46
IUPAC NameN-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid
SMILESC.Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1C[C@@H](N)C[C@H]1CO.Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1C[C@@H](NC(=O)OC(C)(C)C)C[C@H]1CO.O=C(O)C(F)(F)F
InChIInChI=1S/C30H40ClN7O6S.C25H32ClN7O4S.C2HF3O2.CH4/c1-18-15-38-26(33-27(18)37-16-20(13-21(37)17-39)32-29(41)44-30(2,3)4)14-24(34-38)25-8-6-7-11-36(25)28(40)22-12-19(31)9-10-23(22)35-45(5,42)43;1-15-12-33-23(28-24(15)32-13-17(27)10-18(32)14-34)11-21(29-33)22-5-3-4-8-31(22)25(35)19-9-16(26)6-7-20(19)30-38(2,36)37;3-2(4,5)1(6)7;/h9-10,12,14-15,20-21,25,35,39H,6-8,11,13,16-17H2,1-5H3,(H,32,41);6-7,9,11-12,17-18,22,30,34H,3-5,8,10,13-14,27H2,1-2H3;(H,6,7);1H4/t20-,21-,25-;17-,18-,22-;;/m00../s1
InChIKeyXZGPUPNEELNTEG-MVYDLPHFSA-N
XLogP7.49
TPSA341.93 Ų
H-Bond Donors7
H-Bond Acceptors20
Rotatable Bonds13
Heavy Atoms91
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001354.37
LogP ≤ 57.49
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1020

Analyze N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid?
The IUPAC name of N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid (CID 157427964) is N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid.
What is the SMILES notation for N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid?
The canonical SMILES for N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid is C.Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1C[C@@H](N)C[C@H]1CO.Cc1cn2nc([C@@H]3CCCCN3C(=O)c3cc(Cl)ccc3NS(C)(=O)=O)cc2nc1N1C[C@@H](NC(=O)OC(C)(C)C)C[C@H]1CO.O=C(O)C(F)(F)F.
What is the InChIKey of N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid?
The InChIKey is XZGPUPNEELNTEG-MVYDLPHFSA-N. The full InChI is InChI=1S/C30H40ClN7O6S.C25H32ClN7O4S.C2HF3O2.CH4/c1-18-15-38-26(33-27(18)37-16-20(13-21(37)17-39)32-29(41)44-30(2,3)4)14-24(34-38)25-8-6-7-11-36(25)28(40)22-12-19(31)9-10-23(22)35-45(5,42)43;1-15-12-33-23(28-24(15)32-13-17(27)10-18(32)14-34)11-21(29-33)22-5-3-4-8-31(22)25(35)19-9-16(26)6-7-20(19)30-38(2,36)37;3-2(4,5)1(6)7;/h9-10,12,14-15,20-21,25,35,39H,6-8,11,13,16-17H2,1-5H3,(H,32,41);6-7,9,11-12,17-18,22,30,34H,3-5,8,10,13-14,27H2,1-2H3;(H,6,7);1H4/t20-,21-,25-;17-,18-,22-;;/m00../s1.
What are the key properties of N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid?
N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid has a molecular weight of 1354.37 g/mol, XLogP of 7.49, 13 rotatable bonds, 7 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[(2S)-2-[5-[(2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidine-1-carbonyl]-4-chlorophenyl]methanesulfonamide;tert-butyl N-[(3S,5S)-1-[2-[(2S)-1-[5-chloro-2-(methanesulfonamido)benzoyl]piperidin-2-yl]-6-methylpyrazolo[1,5-a]pyrimidin-5-yl]-5-(hydroxymethyl)pyrrolidin-3-yl]carbamate;methane;2,2,2-trifluoroacetic acid is sourced from PubChem (CID 157427964), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).